<object id="cyp8t"></object><nav id="cyp8t"><code id="cyp8t"></code></nav>

        <strike id="cyp8t"></strike>
        <nav id="cyp8t"><code id="cyp8t"><small id="cyp8t"></small></code></nav>
        <small id="cyp8t"></small>

        <form id="cyp8t"></form>
        <wbr id="cyp8t"><tr id="cyp8t"><source id="cyp8t"></source></tr></wbr>
        <wbr id="cyp8t"><th id="cyp8t"><noscript id="cyp8t"></noscript></th></wbr>
        <form id="cyp8t"></form>
        1. <sub id="cyp8t"><listing id="cyp8t"><meter id="cyp8t"></meter></listing></sub>
        2. <form id="cyp8t"><pre id="cyp8t"></pre></form>
        3. <small id="cyp8t"><code id="cyp8t"></code></small>

          Light Up the Hope of Life

          At OrigiMed, a leading precision medicine company, we are devoted to providing the most high quality comprehensive molecular diagnostic technology to assist in personalized treatments for patients and physicians. Advanced and customized ‘one-stop’ solutions from OrigiMed have supported pharmaceutical companies in the development of trials, treatments and companion diagnostic kits. Our aim is to promote further innovative reformation in cancer management in China.

          more >

          Personalized and comprehensive medical solutions for cancer patients

          Covering over 50 types of solid tumors and hematologic neoplasms.

          The first NGS test combing DNA and RNA sequencing in China.

          High-quality publications based on real-world studies.

          Tracing cancer back to its origin, empowering precisely, delivering integrated one-stop solutions for R&D of new treatments

          Central laboratory at international standards.

          Growing experience in new drug R&D and companion diagnostic solutions.

          Explore in biomarker discovery.

          OrigiMed-only system of real-world studies.

          Our innovative platform drives the revolution of precision medicine in China

          The first internet hospital focusing on precision medicine in China.

          International molecular pathological platform.

          Multiple Disciplinary Team (MDT).

          International Molecular Tumor Board (MTB).

          News

          亚洲人成色7777在线观看 噜噜噜夜夜爽| 国产丝袜在线精品丝袜不卡| 99久久国产综合精麻豆| 久久精品国产中国久久| pixaloop| 青青草视频在线观看| 韩国三级中文字幕hd| 亚洲色欲天天天堂色欲网| 80s手机电视电影| 欧美日韩乱码高清视频| 欧美se|